Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Taylor Sandison currently holds 166,836 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Taylor Sandison has been a net buyer of CDTX stock. They have purchased $118.0K and sold $66.0K worth of shares.
Taylor Sandison's most recent insider trade was on Sep 30, 2024, when they sold 166,836 shares at $0.00 per share.
Taylor Sandison serves as Executive at Cidara Therapeutics, Inc. (CDTX). They have executed 21 insider transactions totaling $184.0K over their tenure at the company.
Taylor Sandison holds the position of Executive at Cidara Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Taylor Sandison has shown a buying trading pattern, with $118.0K in total purchases and $66.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Taylor Sandison was on Jun 7, 2017, when they purchased $114.1K worth of CDTX shares. This transaction involved 19,344 shares at $5.90 per share.
Taylor Sandison currently owns 166,836 shares of Cidara Therapeutics, Inc. (CDTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Taylor Sandison's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Taylor Sandison has 21 Form 4 filings on record as an insider at Cidara Therapeutics, Inc..
Set alerts for Taylor Sandison and 40,000+ other insiders.